1. Home
  2. TOUR vs PDSB Comparison

TOUR vs PDSB Comparison

Compare TOUR & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuniu Corporation

TOUR

Tuniu Corporation

HOLD

Current Price

$4.73

Market Cap

73.1M

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$1.08

Market Cap

62.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOUR
PDSB
Founded
2006
2005
Country
China
United States
Employees
N/A
10
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.1M
62.0M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
TOUR
PDSB
Price
$4.73
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
12.6K
1.1M
Earning Date
06-11-2026
05-14-2026
Dividend Yield
17.12%
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.30
N/A
Revenue Next Year
$14.00
N/A
P/E Ratio
$87.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$0.51
52 Week High
$7.79
$1.85

Technical Indicators

Market Signals
Indicator
TOUR
PDSB
Relative Strength Index (RSI) 33.46 49.34
Support Level $0.68 $0.91
Resistance Level $6.50 $1.12
Average True Range (ATR) 0.26 0.12
MACD -0.24 -0.01
Stochastic Oscillator 0.29 42.43

Price Performance

Historical Comparison
TOUR
PDSB

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: